Deutsche Bank’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-165,447
| Closed | -$2.94M | – | 5089 |
|
|
2018
Q3 | $2.94M | Buy |
165,447
+18,721
| +13% | +$332K | ﹤0.01% | 2596 |
|
|
2018
Q2 | $2.03M | Sell |
146,726
-87,086
| -37% | -$1.2M | ﹤0.01% | 2924 |
|
|
2018
Q1 | $2.13M | Buy |
233,812
+233,197
| +37,918% | +$2.12M | ﹤0.01% | 2801 |
|
|
2017
Q4 | $2K | Buy |
615
+519
| +541% | +$1.69K | ﹤0.01% | 4397 |
|
|
2017
Q3 | $0 | Sell |
96
-161,205
| -100% | – | ﹤0.01% | 4629 |
|
|
2017
Q2 | $241K | Buy |
161,301
+62,301
| +63% | +$93.1K | ﹤0.01% | 3695 |
|
|
2017
Q1 | $253K | Buy |
99,000
+54,353
| +122% | +$139K | ﹤0.01% | 3334 |
|
|
2016
Q4 | $113K | Sell |
44,647
-77,113
| -63% | -$195K | ﹤0.01% | 3818 |
|
|
2016
Q3 | $375K | Buy |
121,760
+109,328
| +879% | +$337K | ﹤0.01% | 3247 |
|
|
2016
Q2 | $38K | Sell |
12,432
-9,591
| -44% | -$29.3K | ﹤0.01% | 4258 |
|
|
2016
Q1 | $66K | Buy |
22,023
+9,151
| +71% | +$27.4K | ﹤0.01% | 4001 |
|
|
2015
Q4 | $51K | Sell |
12,872
-13,746
| -52% | -$54.5K | ﹤0.01% | 4109 |
|
|
2015
Q3 | $121K | Sell |
26,618
-212,030
| -89% | -$964K | ﹤0.01% | 3832 |
|
|
2015
Q2 | $1.24M | Buy |
238,648
+48,327
| +25% | +$250K | ﹤0.01% | 2793 |
|
|
2015
Q1 | $1.19M | Sell |
190,321
-134,163
| -41% | -$839K | ﹤0.01% | 2747 |
|
|
2014
Q4 | $2.04M | Buy |
324,484
+288,657
| +806% | +$1.81M | ﹤0.01% | 2628 |
|
|
2014
Q3 | $216K | Sell |
35,827
-78,622
| -69% | -$474K | ﹤0.01% | 3841 |
|
|
2014
Q2 | $753K | Sell |
114,449
-16,131
| -12% | -$106K | ﹤0.01% | 3098 |
|
|
2014
Q1 | $3.11M | Buy |
130,580
+5,742
| +5% | +$137K | ﹤0.01% | 2125 |
|
|
2013
Q4 | $1.33M | Sell |
124,838
-103,583
| -45% | -$1.1M | ﹤0.01% | 2498 |
|
|
2013
Q3 | $3.04M | Sell |
228,421
-1,192
| -0.5% | -$15.9K | ﹤0.01% | 2184 |
|
|
2013
Q2 | $3.01M | Buy |
+229,613
| New | +$3.01M | ﹤0.01% | 1948 |
|